Interested?

We are looking for investors/partners who want to take our unique ReDosa™ reusable syringe to the next level.

What do we Offer

Unique product

ReDosa™ Syringe is one of a kind in an established High Volume Market

Sustainability market fit

The green appeal  is what many green EU and state funds wish to sponsor

Fast time to market

The ReDosa™ syringe will be launched  in less than 2 years

Early break-even

ReDosa™ makes a profit at under a 5% Nordic market share 

The Market

ReDosa™ SYRINGE B2B Market Opportunity- Competitor Landscape.

The Use of Disposable Syringes in million units

Total available market: 3 000 M Served available market: 2 400 M
eu
EU
Total available market: 190 M Served available market: 150 M
nordics
Nordics
Total available market: 70 M Served Market: 55 M
sweden
Sweden

The global syringes market size was valued at USD 19.6 billion in 2023 and is estimated to grow at a CAGR of 10.9% from 2024 to 2032. A syringe is a type of medical equipment that is utilized to insert or withdraw fluid from the body. Source: https://www.gminsights.com/industry-analysis/syringes-market

ONE iNJECTOR REPLACES UP TO 8 SINGLE USE SYRINGES

Profitable growth

Fast to market

  • Product launch < 2 y
  • Profitable at under 5% Nordic market share

Low cost of Sales

  • High-volume business
  • Tender Business

Strong Gross Margins

  • Positive gross margins at small Volumes
  • Lower production costs

Market size and growth

The global syringes market size was valued at USD 19.6 billion in 2023 and is estimated to grow at a CAGR of 10.9% from 2024 to 2032.

Growth Drivers

  • Rising chronic diseases and geriatric population
  • Increasing vaccination initiatives
  • Growing technological advancements focusing on patient safety
  • Need for cheaper silicone free syringes due to rise in biologics and biosimilars research activities nee
  • Hospitals need to save money and comply with plastic waste policies

Market Opportunities

  • Environmental considerations push the market toward recyclable resin grades and lower-mass designs
  • Increased adoption of advanced technology for new Product Developments
  • Healthcare providers, Governments have been pushing for plastic waste policies
  • Offering better functionality for a lower cost
  • Offering easy dosing and pain free injections

While competitors mainly focus on recycling,  Domeject  is currently the only player working on plastic reduction at the source

Interested?

We are looking for partners who want to take our unique ReDosa™ syringe to the next level.